News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
295,784 Results
Type
Article (16641)
Company Profile (289)
Press Release (278854)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (91700)
Career Advice (290)
Deals (14871)
Drug Delivery (42)
Drug Development (52323)
Employer Resources (38)
FDA (6138)
Job Trends (6664)
News (160712)
Policy (11072)
Tag
Academia (1067)
Accelerated approval (2)
Adcomms (12)
Allergies (55)
Alliances (22808)
ALS (72)
Alzheimer's disease (885)
Antibody-drug conjugate (ADC) (110)
Approvals (6172)
Artificial intelligence (135)
Autoimmune disease (19)
Automation (7)
Bankruptcy (112)
Best Places to Work (5316)
BIOSECURE Act (8)
Biosimilars (52)
Biotechnology (239)
Bladder cancer (61)
Brain cancer (20)
Breast cancer (175)
Cancer (1573)
Cardiovascular disease (122)
Career advice (250)
Career pathing (5)
CAR-T (125)
Cell therapy (350)
Cervical cancer (11)
Clinical research (42718)
Collaboration (569)
Compensation (283)
Complete response letters (14)
COVID-19 (1150)
CRISPR (44)
C-suite (177)
Cystic fibrosis (79)
Data (1657)
Denatured (11)
Depression (34)
Diabetes (150)
Diagnostics (1630)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (87)
Drug pricing (38)
Drug shortages (6)
Duchenne muscular dystrophy (93)
Earnings (37484)
Editorial (22)
Employer branding (5)
Employer resources (35)
Events (51525)
Executive appointments (482)
FDA (6939)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (531)
Gene editing (103)
Generative AI (11)
Gene therapy (267)
GLP-1 (408)
Government (1295)
Grass and pollen (2)
Guidances (71)
Healthcare (7595)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (98)
Indications (21)
Infectious disease (1219)
Inflammatory bowel disease (119)
Inflation Reduction Act (9)
Influenza (21)
Intellectual property (69)
Interviews (36)
IPO (8122)
IRA (16)
Job creations (1650)
Job search strategy (230)
Kidney cancer (7)
Labor market (13)
Layoffs (244)
Leadership (5)
Legal (1643)
Liver cancer (36)
Lung cancer (213)
Lymphoma (108)
Machine learning (5)
Management (10)
Manufacturing (169)
MASH (59)
Medical device (3324)
Medtech (3325)
Mergers & acquisitions (7105)
Metabolic disorders (417)
Multiple sclerosis (56)
NASH (13)
Neurodegenerative disease (73)
Neuropsychiatric disorders (25)
Neuroscience (1318)
NextGen: Class of 2025 (2430)
Non-profit (1145)
Now hiring (23)
Obesity (205)
Opinion (112)
Ovarian cancer (67)
Pain (46)
Pancreatic cancer (62)
Parkinson's disease (124)
Partnered (9)
Patents (143)
Patient recruitment (85)
Peanut (36)
People (27260)
Pharmaceutical (49)
Pharmacy benefit managers (6)
Phase I (14934)
Phase II (19744)
Phase III (12745)
Pipeline (987)
Policy (60)
Postmarket research (966)
Preclinical (6229)
Press Release (33)
Prostate cancer (65)
Psychedelics (35)
Radiopharmaceuticals (219)
Rare diseases (302)
Real estate (3257)
Recruiting (13)
Regulatory (9308)
Reports (17)
Research institute (1042)
Resumes & cover letters (44)
Rett syndrome (4)
RNA editing (5)
RSV (12)
Schizophrenia (62)
Series A (103)
Series B (67)
Service/supplier (1)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (118)
Sponsored (13)
Startups (2088)
State (2)
Stomach cancer (5)
Supply chain (29)
Tariffs (15)
The Weekly (37)
Vaccines (249)
Venture capitalists (33)
Weight loss (118)
Women's health (17)
Worklife (2)
Date
Today (108)
Last 7 days (584)
Last 30 days (1858)
Last 365 days (20218)
2025 (7156)
2024 (21528)
2023 (23646)
2022 (28279)
2021 (29411)
2020 (25206)
2019 (18722)
2018 (13732)
2017 (15271)
2016 (13229)
2015 (16131)
2014 (11725)
2013 (8491)
2012 (8614)
2011 (8783)
2010 (8385)
Location
Africa (205)
Alabama (44)
Alaska (2)
Arizona (60)
Arkansas (5)
Asia (18894)
Australia (3104)
California (4189)
Canada (1209)
China (382)
Colorado (164)
Connecticut (162)
Delaware (118)
Europe (40346)
Florida (524)
Georgia (128)
Idaho (21)
Illinois (262)
India (10)
Indiana (110)
Iowa (3)
Japan (89)
Kansas (64)
Kentucky (7)
Louisiana (5)
Maine (16)
Maryland (514)
Massachusetts (3331)
Michigan (83)
Minnesota (158)
Mississippi (1)
Missouri (26)
Montana (16)
Nebraska (5)
Nevada (22)
New Hampshire (19)
New Jersey (1078)
New Mexico (14)
New York (1129)
North Carolina (599)
North Dakota (5)
Northern California (1860)
Ohio (124)
Oklahoma (9)
Oregon (24)
Pennsylvania (807)
Puerto Rico (7)
Rhode Island (21)
South America (295)
South Carolina (5)
Southern California (1623)
Tennessee (28)
Texas (494)
United States (14500)
Utah (68)
Virginia (87)
Washington D.C. (33)
Washington State (381)
West Virginia (2)
Wisconsin (18)
295,784 Results for "nine square therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Nine Square Therapeutics Awarded $4.5 Million Grant from The Michael J. Fox Foundation to Advance Development of Novel Parkin Activators
Nine Square Therapeutics announced that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research.
September 12, 2023
·
3 min read
Press Releases
Eupraxia Pharmaceuticals Announces Sustained Positive Treatment Outcomes in Patients with Eosinophilic Esophagitis (EoE) After Nine Months of Receiving EP-104GI
May 5, 2025
·
13 min read
Business
Nine Square Therapeutics Appoints John Hood to Board of Directors
Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to discover and develop novel small-molecule therapeutics for life-threatening neurodegenerative diseases, such as Parkinson’s disease and ALS, announced today that John Hood, Ph.D., has joined the company’s Board of Directors.
September 13, 2022
·
2 min read
Press Releases
Cytonics Announces Successful Completion of Phase 1 Study for First Nine Patients in CYT-108 Clinical Trial
January 21, 2025
·
6 min read
Business
Nine Square Therapeutics Appoints Robert Paul as CEO
Nine Square Therapeutics announced today that Robert Paul , M.D., Ph.D. , has joined the company as its chief executive officer.
January 11, 2022
·
2 min read
Press Releases
Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024
October 30, 2024
·
19 min read
Job Trends
9 Companies Hiring in Massachusetts
Looking for a biopharma job in Massachusetts? Check out the
BioSpace
list of nine companies hiring life sciences professionals like you.
April 17, 2025
·
2 min read
·
Angela Gabriel
BioMidwest
Forge Biologics Announces Nine Presentations at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Forge Biologics Announces Nine Presentations at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting.
April 30, 2024
·
4 min read
Collaboration
Takeda Pumps $770M Into Another BridGene Pact to Hit ‘Undruggable’ Targets
BridGene strikes another partnership with Takeda as the latter company continues its dealmaking streak, following high-ticket agreements with Keros Therapeutics, AC Immune and Degron Therapeutics in the past nine months.
February 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Genmab Announces Financial Results for the First Nine Months of 2024
November 6, 2024
·
6 min read
1 of 29,579
Next
